Literature DB >> 9359529

Effect of hepatocyte growth factor on early human haemopoietic cell development.

M Z Ratajczak1, W Marlicz, J Ratajczak, M Wasik, B Machalinski, A Carter, A M Gewirtz.   

Abstract

Hepatocyte growth factor (HGF) stimulates cell proliferation, differentiation and migration by binding to its receptor, MET R. Whether the HGF/MET R axis plays an important regulatory role in human haemopoietic cell growth is an unresolved issue. To investigate this situation, we employed several complementary strategies including RT-PCR, FACS analysis, and mRNA perturbation with oligodeoxynucleotides (ODN). We found that very primitive, FACS sorted, CD34+ Kit+ marrow mononuclear cells (MNC) failed to express RT-PCR detectable MET R mRNA. In contrast, MET R expression was easily detectable by RT-PCR in marrow stroma fibroblasts, in cells isolated from BFU-E and CFU-GM colonies, and in unselected normal MNC. Subsequent FACS analysis revealed that MET R protein was detectable on approximately 5% of the latter cells. HGF, at concentrations of 1-50 ng/ml, had no demonstrable effect on survival or cloning efficiency of normal CD34+ MNC in serum-free cultures. Antisense ODN mediated perturbation of MET R mRNA expression in normal CD34+ MNC, with FACS documented decline in protein expression, had no effect on the ability of these cells to give rise to haemopoietic colonies of any lineage. We also examined the biology of HGF/MET R expression in malignant haemopoietic cells. Using the strategies described above, we found that MET R mRNA was expressed in many human haemopoietic cell lines, and that the protein was expressed at high levels on HTLV transformed T lymphocytes. Wild-type CML and AML blast cells also expressed MET mRNA, and HGF was able to co-stimulate CFU-GM colony formation in approximately 20% of cases studied. Therefore, although the HGF/MET R axis appears to be dispensable for normal haemopoietic cell growth, it may play a role in the growth of malignant haemopoietic progenitor cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9359529     DOI: 10.1046/j.1365-2141.1997.3563170.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  10 in total

1.  Ligand-induced MET signaling as targetable codependence in acute myeloid leukemia.

Authors:  Stefan Fröhling
Journal:  Haematologica       Date:  2012-08       Impact factor: 9.941

2.  shRNA-mediated decreases in c-Met levels affect the differentiation potential of human mesenchymal stem cells and reduce their capacity for tissue repair.

Authors:  Ivana Rosová; Daniel Link; Jan A Nolta
Journal:  Tissue Eng Part A       Date:  2010-08       Impact factor: 3.845

3.  Hepatocyte growth factor/scatter factor released during peritonitis is active on mesothelial cells.

Authors:  T Rampino; G Cancarini; M Gregorini; P Guallini; M Maggio; A Ranghino; G Soccio; A Dal Canton
Journal:  Am J Pathol       Date:  2001-10       Impact factor: 4.307

4.  Identification of basophils as a major source of hepatocyte growth factor in chronic myeloid leukemia: a novel mechanism of BCR-ABL1-independent disease progression.

Authors:  Sabine Cerny-Reiterer; Viviane Ghanim; Gregor Hoermann; Karl J Aichberger; Harald Herrmann; Leonhard Muellauer; Andreas Repa; Christian Sillaber; Andrew F Walls; Matthias Mayerhofer; Peter Valent
Journal:  Neoplasia       Date:  2012-07       Impact factor: 5.715

5.  Effect of hepatocyte growth factor (HGF) on the level of Survivin & XIAP expression in several human cancer cell lines, after treating with DNA damaging agent.

Authors:  Kianoosh Keyhanian; Rosita Edalat; Akbar Oghalaei; Nayere Askary; Arghavan Golshani; Mansour Salehi; Ramin Sarrami-Forooshani; Mohammad Ali Shokrgozar
Journal:  Mol Cell Biochem       Date:  2007-05-30       Impact factor: 3.396

Review 6.  The Hepatocyte Growth Factor (HGF)/Met Axis: A Neglected Target in the Treatment of Chronic Myeloproliferative Neoplasms?

Authors:  Marjorie Boissinot; Mathias Vilaine; Sylvie Hermouet
Journal:  Cancers (Basel)       Date:  2014-08-12       Impact factor: 6.639

7.  Dnmt3b catalytic activity is critical for its tumour suppressor function in lymphomagenesis and is associated with c-Met oncogenic signalling.

Authors:  Katarina Lopusna; Pawel Nowialis; Jana Opavska; Ajay Abraham; Alberto Riva; Rene Opavsky
Journal:  EBioMedicine       Date:  2021-01-05       Impact factor: 8.143

Review 8.  Cancer non-stem cells as a potent regulator of tumor microenvironment: a lesson from chronic myeloid leukemia.

Authors:  Naofumi Mukaida; Yamato Tanabe; Tomohisa Baba
Journal:  Mol Biomed       Date:  2021-03-10

Review 9.  Contribution of human hematopoietic stem cells to liver repair.

Authors:  Ping Zhou; Louisa Wirthlin; Jeannine McGee; Geralyn Annett; Jan Nolta
Journal:  Semin Immunopathol       Date:  2009-06-17       Impact factor: 9.623

Review 10.  The underestimated role of basophils in Ph+ chronic myeloid leukaemia.

Authors:  Peter Valent; Hans-Peter Horny; Michel Arock
Journal:  Eur J Clin Invest       Date:  2018-08-06       Impact factor: 4.686

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.